WAY - Waystar Health Market Capitalization-to-Revenue Ratio

Corporate company logo of Waystar Health (WAY)

Waystar Holding Corp. implements scalable software for medical billing automation, minimizing insurance claim denials. The digitalization of payments reduces paper turnover, thereby lowering the environmental impact. Cloud hosting is delegated to external providers while maintaining full control over the code. The current value has stabilized at 4.30, which clearly demonstrates the price-to-sales ratio, helping to assess the proportionality of market capitalization to actual cash flows.

WAY: Waystar Inc. Price-to-Revenue Ratio 06/08/2024 - 11/13/2026

Analytical breakdowns for Waystar Inc. (WAY)

- share price and consensus valuation forecast:
- market capitalization statistics:
General company analysis:WAY, waystar.com
Product sample of waystar.com

Waystar Holding Corp. (WAY) operates within an isolated segment of the US healthcare market, which minimizes external risks and establishes its revenue as a stable foundation for valuation. The price-to-sales ratio determines the premium for the scalability of its IT solutions, allowing the current P/S metric to distinguish organic revenue growth from speculative price overheating.

Competitors of Waystar Holding Corp.

VEEV (veeva.com) - Market Capitalization-to-Revenue Ratio|Doximity - Market Cap to Revenue|Market Capitalization-to-Revenue Ratio HQY|CorVel Healthcare - P/S Multiple|Market Capitalization-to-Revenue Ratio PRVA (Privia Medical Group)|Huron Consulting Group (HURN) - Price-to-Revenue Ratio|Price to Sales certara.com (CERT)|Price-to-Revenue Ratio Omnicell|Price-to-Revenue Ratio GDRX|P/S Multiple SDGR|Phreesia Health - Market Cap to Revenue Ratio|P/S Multiple OMDA (Omada Health Inc)|Price-to-Revenue Coefficient evolenthealth.com (EVH)|HSTM - Price-to-Revenue Ratio|DH (Definitive Healthcare Corp) - Market Cap to Revenue Ratio|CCSI: P/S Multiple|Price-to-Revenue Multiple Agilon Health Corp AGL|Market Cap to Revenue ABSI|SY: Market Capitalization-to-Revenue Ratio|P/S Multiple NRC|Market Cap to Revenue Spok Holdings Inc SPOK|Price-to-Revenue Ratio OptimizeRx Corp. OPRX|TruBridge Corp (TBRG) - Price to Sales|SLP - Price-to-Revenue Ratio|Market Capitalization-to-Revenue Ratio SOPH (SOPHiA GENETICS SA)|Health Catalyst (HCAT) - Price-to-Revenue Ratio|Price-to-Sales Ratio CCLD (CareCloud)|Market Cap to Revenue RSSS|DLH Holdings Corp (DLHC) - Price-to-Revenue Coefficient|Market Cap to Revenue ONMD (OneMedNet Corporation)|Market Cap to Revenue scienture.com SCNX|P/S Multiple HCTI (Healthcare Triangle, Inc.)|P/S Multiple iSpecimen Inc ISPC|BFRG: Market Cap to Revenue|Price to Sales SCWorx Inc|MSPR: P/S Multiple|ICCT - Price-to-Revenue Coefficient|Market Cap to Revenue MEDS|ORGS (Orgenesis Inc) - Market Cap to Sales Volume|Market Cap to Revenue RCM (R1 RCM Inc.)|SHCR (Sharecare Inc) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Streamline Health Solutions STRM|SYRA - Market Cap to Revenue|ApolloMed - P/S Multiple|Price to Sales Model N Inc|NXGN: P/S Multiple